Includes: Nanostics research update, 2026 Pathfinders Award, More men living longer with incurable prostate cancer report finds,

Includes: AI-Powered Pathology Biomarker Predicts Survival, First commercial procedures performed with Zenflow Spring for BPH, Cancer’s ‘rogue DNA’,

Includes: New drug combination may help treat advanced prostate cancer, Half of prostate cancer focal therapy use falls outside guideline-supported groups,

Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,

Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,

Includes: Study finds prostate cancer overdiagnosis rises sharply with age, experimental drug shows promise for patients with advanced prostate cancer,

Includes: exposing a new weakness in prostate tumors, delaying disease progression, prostate cancer overdiagnosis rises sharply with age,

Includes: Researchers praise results of new prostate cancer treatment, glowing cancer cells could cut need for biopsies, Prostate cancer deaths to decrease,

Includes: New characteristics of aggressive prostate cancer identified, how to treat recurring prostate cancer, apalutamide vs. darolutamide in mCSPC,

Includes: Spotlighting the Top 10 FDA Oncology Approvals in 2025, CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction,